155 related articles for article (PubMed ID: 8540031)
1. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
[No Abstract] [Full Text] [Related]
2. Automated processing of human vertebral body bone marrow yields preparations with stem cell content similar to that obtained with traditional manual preparation.
Kenyon NS; Xu XM; Knapp J; Selvaggi GS; Bottino R; Kong SS; Qian T; Linetsky E; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3418. PubMed ID: 8540030
[No Abstract] [Full Text] [Related]
3. Suitability of neonatal vertebral body marrow for transplant applications.
Kong SS; Selvaggi G; Kenyon N; Knapp J; Olson L; Tzakis AG; Miller J; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3416. PubMed ID: 8540028
[No Abstract] [Full Text] [Related]
4. A simple method for depletion of bone fragments from human vertebral body marrow.
Kong SS; Selvaggi G; Kenyon N; Bottino R; Linetsky E; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3417. PubMed ID: 8540029
[No Abstract] [Full Text] [Related]
5. Effect of preservation conditions on human vertebral body marrow.
Kong SS; Kenyon NS; Brendel M; Tzakis AG; Miller J; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3415. PubMed ID: 8540027
[No Abstract] [Full Text] [Related]
6. CD34 positive cell selection by immunomagnetic techniques.
Bigas A; Amill B; Canals C; Tugues D; García J
Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
[No Abstract] [Full Text] [Related]
7. Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assay.
Janssen WE; Lee C; Farmelo MJ; Smilee R; Barth K; Fields KK; Zorsky PE; Elfenbein GJ
Prog Clin Biol Res; 1992; 377():513-21. PubMed ID: 1279719
[No Abstract] [Full Text] [Related]
8. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow obtained from vertebral bodies: cell isolation, phenotyping, progenitor assay, and transplantation.
Fontes P; Rao AS; Ricordi C; Rybka WB; Dodson FS; Broznick B; Lu L; Zeevi A; Thomson AW; Vasko C
Transplant Proc; 1994 Dec; 26(6):3406-7. PubMed ID: 7998194
[No Abstract] [Full Text] [Related]
10. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
11. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
Cipolone KM; Carter CS; Yu M; Cottler-Fox M
Prog Clin Biol Res; 1994; 389():667-73. PubMed ID: 7535463
[No Abstract] [Full Text] [Related]
12. Immunogenicity and stem cell content of class II depleted human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Ann N Y Acad Sci; 1995 Dec; 770():361-3. PubMed ID: 8597374
[No Abstract] [Full Text] [Related]
13. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
Chang Q; Harvey K; Akard L; Thompson J; Dugan MJ; English D; Jansen J
Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064
[TBL] [Abstract][Full Text] [Related]
14. A manual method for processing bone marrow using percoll: characteristics of the transfusion product.
Glasser L; Smith DM; Fiederlein RL; Wood M
Prog Clin Biol Res; 1994; 389():685-94. PubMed ID: 7700936
[No Abstract] [Full Text] [Related]
15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
16. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
17. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
18. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells.
Layton DS; Strom AD; O'Neil TE; Broadway MM; Stephenson GL; Morris KR; Muralitharan M; Sandrin MS; Ierino FL; Bean AG
Exp Hematol; 2007 Jan; 35(1):171-8. PubMed ID: 17198886
[TBL] [Abstract][Full Text] [Related]
19. Surgical implantation of bioengineered bone marrow tissue into rats.
Naughton BA; San Román J; Sibanda B; Weintraub JP; Morales DL; Kamali V
Prog Clin Biol Res; 1994; 389():711-25. PubMed ID: 7700939
[No Abstract] [Full Text] [Related]
20. Induction of allogeneic unresponsiveness in adult dogs by irradiation and bone marrow transplantation: implication of Ia-positive bone marrow stem cells.
Rapaport FT; Bachvaroff RJ; Asari H; Sato K; Chanana AD; Joel DD; Cronkite EP
Ann N Y Acad Sci; 1985; 459():22-5. PubMed ID: 3913369
[No Abstract] [Full Text] [Related]
[Next] [New Search]